Aussie insurers prioritise governance as product design rules bite
March 31 2022 by Blake Evans-Pritchard
-
Dali owner, operator reach US$100m settlement over Baltimore bridge collapse
- October 25
Singapore-based Grace Ocean and Synergy Marine, the owner and operator of the cargo ship that struck the Francis Scott Key Bridge in the US earlier this year, have agreed to pay the amount to the US federal government.
-
Australian consumer body urges regulatory intervention on general insurance guidelines
- October 23
Australian Consumers Insurance Lobby highlighted inadequate standards prevalent in expert reports while handling insurance claims processes.
-
ASIC sues QBE for allegedly misleading customers over loyalty discounts
- October 23
The corporate regulator said the insurer's pricing model reduced the discounts promised to customers on policy renewals.
-
India defers roll out of IFRS 17 equivalent indefinitely: report
- October 3
Insurers can submit financial statements under the earlier Ind AS104 regime till the IRDAI notifies the implementation of the Ind AS 117standard.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
